The activation of the PI3K/AKT pathway has been identified to inhibit the function of FOXO3, and the repressed expression of FOXO3 in normal fibroblasts contributes to the IPF fibroblast phenotype51. The gene discussed is FOXO3; the disease is idiopathic pulmonary fibrosis.